People interested in participating in the study are being encouraged to sign up to the NHS COVID-19 Vaccine Research Registry.
There is no vaccine for COVID-19 yet, but a handful of companies such as Pfizer and Moderna Inc MRNA.O are in final-stage trials of their experimental vaccines.
Wednesday's announcement came days after the Kremlin said that another vaccine "registered" in August had only just begun a second round of Phase III safety and efficacy trials.
The president said that a Chinese vaccine would also be delivered to the country.
Marsudi was to meet with UK-based pharmaceutical giant AstraZeneca on Wednesday to cement a vaccine-dose deal for Indonesia, the world's fourth most populous nation with almost 270 million people, which has struggled to contain soaring infection rates.
AstraZeneca put the brakes on theirs last month because of a neurological complication in a volunteer in Britain.
But trials for both AstraZeneca's and Johnson & Johnson's vaccines are now on hold, due to safety concerns.
Experts estimated that a vaccine could be approved for emergency use sometime in November or December but wouldn't commit to the possibility of it coming before the Nov. 3 national elections.
Russian Federation became the first country to give regulatory approval to a Covid-19 vaccine in August when Sputnik V was officially registered ahead of large-scale clinical trial, drawing criticism from some quarters in the scientific community. First of all, in Venezuela, workers in the healthcare system and the education system, as well as elderly people and those with chronic diseases, will be vaccinated.
The study in Bournemouth is looking for people in the county from the most "at risk" Covid-19 groups to take part.
Vaxart founder and chief scientific officer Sean Tucker said: "We are advancing VXA-CoV2-1 into clinical development based on the strength of preclinical data that showed that the vaccine is capable of inducing both a robust systemic immune response and a strong mucosal immune response, specifically in the lungs".
Despite the delays, Fauci's prediction that the general population could be vaccinated by the end of Q1 is still in line with his comments to Congress last month that the U.S. could have enough coronavirus vaccine doses for all Americans by April.